Downtrend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend down since Nov 4 · inside the Ichimoku cloud · RSI 0 (oversold) · MACD above its signal · at its 52-week low
None of the 29 investors followed here reported a position in FFNTF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a FFNTF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2024 | Pratte (Trevor John)10% Security Holder of Issuer | Acquisition or disposition in the public market at price 0.06 per share. | 53K | $3.39K |
| Aug 18, 2024 | Rosen (Joshua Nathaniel)10% Security Holder of Issuer | Acquisition or disposition in the public market at price 0.06 per share. | 53K | $3.39K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | -80.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −80.0% | ||
| 2025 | -15.2 | 100.9 | -39.1 | -85.7 | -90.0 | 50.0 | -66.7 | 800.0 | -88.9 | 0.0 | -50.0 | 0.0 | −99.6% |
| 2024 | 14.7 | -14.0 | 14.3 | 9.2 | -18.2 | -14.0 | 18.5 | -50.5 | -10.7 | -14.4 | -23.4 | -54.2 | −86.4% |
| 2023 | 6.3 | -7.9 | -21.9 | -7.1 | -0.5 | -5.5 | -10.2 | -9.3 | 96.9 | -20.0 | -41.0 | -15.8 | −57.5% |
| 2022 | -34.8 | 29.1 | -5.9 | -7.5 | 1.4 | -26.7 | 9.1 | -6.9 | -42.0 | 26.5 | 13.0 | -49.6 | −76.9% |
| 2021 | 20.9 | 52.7 | -29.8 | 10.2 | 1.4 | -4.4 | -8.1 | -6.8 | -2.9 | 0.3 | -1.7 | -2.2 | +11.0% |
| 2020 | 11.0 | -33.9 | -6.1 | -6.5 | 45.9 | -0.7 | 47.0 | 16.6 | -20.8 | 6.9 | 26.9 | 17.6 | +102.2% |
| 2019 | 13.0 | 72.5 | 47.9 | -23.1 | -33.5 | 12.2 | -15.0 | -43.5 | -0.7 | -23.1 | -1.5 | 11.1 | −33.5% |
| 2018 | 0.0 | 0.0 | 112.2 | 16.7 | -21.0 | 8.2 | -13.0 | 14.8 | -10.1 | -32.7 | 48.5 | -0.5 | +89.0% |
| 2017 | 0.0 | 12.8 | -0.9 | -10.6 | 0.0 | 0.0 | 29.7 | 7.9 | 0.0 | 0.0 | 0.0 | 0.0 | +40.0% |
| 2016 | 0.0 | 0.0 | 0.0 | -52.0 | 54.8 | 0.0 | 0.0 | 0.0 | 0.2 | -25.1 | 0.0 | 0.0 | −44.3% |
| 2015 | 0.0 | 0.0 | -12.9 | 0.0 | 0.0 | 159.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +125.8% |
| 2014 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 816.7 | -3.6 | 0.0 | -41.5 | +416.7% |
| 2013 | 0.0 | 0.0 | 0.0 | 0.0 | -96.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −96.9% |
| 2012 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2011 | 13.3 | -3.5 | 7.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +17.1% |
| 2010 | 1.2 | -0.6 | -22.4 | 7.0 | -5.1 | 13.8 | -18.9 | -31.7 | 33.9 | −33.0% |
No analyst coverage for this instrument.
4Front Ventures Corp. engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States. The company operates through three segments: Illinois, Massachusetts, and Corporate. It offers flower, pre-rolls, vaporizers, concentrates, edibles, tinctures and soft gels, capsules, and topicals, as well as provides a vertically integrated supply chain to serve both medical and recreational markets. The company owns, operates, and manages cultivation and manufacturing facilities and retail centers; sales CBD products to third-party consumers; leases real estate in the state of Washington; and engages in other corporate activities. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.
No recent headlines.